Segment and Geographic Information (Tables)

3 Months Ended

Mar. 31, 2013

Product revenue by product group is as follows:

	Three Months Ended March 31,
	2013		2012
Orthobiologics	$	11,283,547	$	10,116,845
Surgical		988,864		983,628
Dermal		241,584		501,315
Ophthalmic		928,458		1,323,994
Veterinary		1,052,036		687,546
	$	14,494,489	$	13,613,328

Product Revenue by Geographic Location and Percentage of Total Product Revenue

Product revenue by geographic location in total and as a percentage of total product revenue, for the three months ended March 31, 2013 and 2012 are as follows:

		Three Months Ended March 31,
		2013					2012
				Percentage of					Percentage of
Geographic Location:		Revenue		Revenue			Revenue		Revenue
	United States	$	11,566,779		80	%	$	10,390,045		76	%
	Europe		1,547,914		11	%		1,770,752		13	%
	Other		1,379,796		9	%		1,452,531		11	%
	Total	$	14,494,489		100	%	$	13,613,328		100	%

- Definition

Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.

+ References+ Details